July 20, 2017 12:49 PM ET

Healthcare Equipment and Supplies

Company Overview of Access Bio, Inc.

Company Overview

Access Bio, Inc. researches, develops, manufactures, and sells in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company was founded in 2001 and is headquartered in Somerset, New Jersey.

65 Clyde Road

Suite A

Somerset, NJ 08873

United States

Founded in 2001

Phone:

732-873-4040

Key Executives for Access Bio, Inc.

Access Bio, Inc. does not have any Key Executives recorded.

Access Bio, Inc. Key Developments

GE, Global Good Licensing Deal with Access Bio Brings Asymptomatic Malaria Rapid Diagnostic Tests to Market

Intellectual Ventures’ Global Good Fund and GE have signed a licensing agreement with Access Bio to manufacture and distribute innovative diagnostic technologies that will help global health workers to more rapidly identify asymptomatic malaria in low-resource regions around the world. Identifying these low-level infections is considered critical to directing efforts towards malaria elimination. The new diagnostics technologies for malaria detection were co-developed by a team of scientists and engineers at GE’s Global Research Center in Upstate New York and Global Good. GE Ventures, GE’s strategic arm to accelerate innovation and growth with partners, drove the commercialization model for the technology and the licensing agreement between GE, Global Good and Access Bio. The agreement covers a highly-sensitive diagnostic test that identifies key proteins present in malaria, as well as Plasmodium lactate dehydrogenase (pLDH) RDT to detect malarial parasites. The agreement also includes technology to create malaria serology tests for Plasmodium antibodies which can measure a population’s past exposure to the disease.

Access Bio, Inc. - Special Call

To discuss 2016 business results and promote investor understanding through an explanation of the status and future plans for the company

Access Bio, Inc., Annual General Meeting, Mar 24, 2017

Access Bio, Inc., Annual General Meeting, Mar 24, 2017, at 10:30 Korea Standard Time.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Buyback
November 14, 2016
--
Private Placement
October 24, 2016
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Access Bio, Inc., please visit www.accessbio.net. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.